๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Zigong
Clinical trial register · China

Clinical Trials in Zigong, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Zigong

7 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Clinical Trial of Recombinant RSV Vaccine (CHO Cell) (Adjuvanted) in Chinese Population Aged 18 Years and Older.
NCT07582796Respiratory Syncytial Virus Infections
Ab&B Bio-tech Co., Ltd.JS
Phase 1/2
470
Zigong
2026-05-14
Recruiting
Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer
NCT06768931Breast Cancer, Triple Negative Breast Cancer (TNBC), Early Stage Breast Cancer, Immunotherapy
Sun Yat-sen University
Phase 2
192
Lanzhou, Dongguan, Guangzhou, Zhanjiang, Zigong
2026-04-01
Recruiting
Identifying Local Field Potential Biomarkers for Obsessive-compulsive Disorder Treatment With Deep Brain Stimulation
NCT06542224Obsessive-Compulsive Disorder
West China Hospital
Not applicable
16
Chengdu, Zigong
2024-08-03
Active, closed
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
NCT05878769Chronic Obstructive Pulmonary Disease
Hoffmann-La Roche
Phase 3
2,000
Hefei, Beijing, Zunyi, Wuhan, Xuzhou, Pingxiang, Shanghai, Zigong
2023-06-28
Not yet open
Intracranial Hemorrhage Risk of Intensive Statin in Acute Ischemic Stroke With Cerebral Microbleeds
NCT05589454Acute Ischemic Stroke, Cerebral Microbleeds
Sichuan Provincial People's Hospital
Phase 4
344
Chongqing, Chengdu, Ya'an, Zigong
2023-01
Recruiting
Correlation Between Deep Medullary Veins and Cognitive Dysfunction in Cerebral Small Vessel Disease
NCT05715710Cerebral Small Vessel Disease
Zigong No.1 Peoples Hospital
Observational
200
Zigong
2022-01-01
By invitation
Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors
NCT05423977HER2-positive Advanced Solid Tumor
Hangzhou Adcoris Biopharmacy Co., Ltd
Phase 1
36
Zigong
2021-12-17
Rows per page Showing 1–7 of 7
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/city/zigong

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 7 of those studies with a site in Zigong.

How many clinical trials are recruiting in Zigong?

4 of the 7 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 1 have not yet opened recruitment, 1 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Zigong), 7 studies
PhaseStudiesRecruitingShare
Not applicable1114.3%
Observational1114.3%
Phase 11014.3%
Phase 1/21114.3%
Phase 21114.3%
Phase 31014.3%
Phase 41014.3%

Most active sponsors

Lead sponsors with the most studies (Zigong)
Lead sponsorStudiesRecruiting
Ab&B Bio-tech Co., Ltd.JS11
Hangzhou Adcoris Biopharmacy Co., Ltd10
Hoffmann-La Roche10
Sichuan Provincial People's Hospital10
Sun Yat-sen University11
West China Hospital11
Zigong No.1 Peoples Hospital11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.